Novavax | NVAX - Ordinary Share Capital

Stock Price
8.45
Daily Change
-0.50 -5.59%
Monthly
-16.42%
Yearly
20.71%
Q1 Forecast
9.06

Novavax reported $162.58M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Adma Biologics USD 237.88M 457K Dec/2025
Agenus USD 35.32M 2.51M Dec/2025
AstraZeneca USD 1.55B 206K Dec/2025
BioCryst Pharmaceuticals USD 213.06M 2.54M Dec/2025
Cassava Sciences USD 48.31M 0 Dec/2025
Geron USD 638.36M 338K Dec/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
MannKind USD 307.83M 806K Dec/2025
Merck USD 2.49B 15.79M Sep/2025
Minerva Neurosciences USD 1000 0 Sep/2024
Moderna USD 391M 2M Sep/2025
Novartis USD 1.91B 10.64M Dec/2025
Novavax USD 162.58M 106K Dec/2025
Pfizer USD 5.69B 1000K Sep/2025
Sarepta Therapeutics USD 104.96M 196K Dec/2025
TG Therapeutics USD 155.21M 2.81M Sep/2025